Drug pricing remains a red-hot issue in Congress, as is clear from the more than 30-pharma-related bills introduced this term. As potential deal making heats up, legislators are seeking a variety of ways to curb drug costs, from setting limits on price increases to speeding approval of generics, allowing importation of lower-cost drugs, and altering market exclusivities. (See chart at end of story).
Pharma Legislation: From Pricing To Patents
Our table details more than 30 pharma-related bills introduced in the US Congress this year that target drug pricing, generics, patents, market exclusivity, and FDA approval of opioids.
